Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
Holders of 5% or more of TARS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tarsus Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| RTW Investments, LP | 13G/A | 8.10%3.42M shares | – | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 7.40%3.09M shares | – | Apr 24, 20251 filing | Apr 24, 2025 | SEC |
| Deep Track Capital, LP | 13G/A | 7.11%3.00M shares | +1.51 ppfrom 5.60% | Jul 28, 20252 filings | Nov 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on Tarsus Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20261:34 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 2.80%1.19M shares | −3.10 ppfrom 5.90%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20258:23 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 7.11%3.00M shares | +1.51 ppfrom 5.60% | Sep 30, 2025 | SEC |
| Aug 14, 20258:08 AM ET | RTW Investments, LPand 1 other | 13G/A | 8.10%3.42M shares | – | Jun 30, 2025 | SEC |
| Jul 28, 20255:00 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.60%2.35M shares | New | Jul 21, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 5.90%2.45M shares | – | Mar 31, 2025 | SEC |
| May 7, 202511:27 AM ET | Morgan Stanley | 13G/A | 4.70%1.94M shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 24, 20259:12 AM ET | BlackRock, Inc. | 13G/A | 7.40%3.09M shares | – | Mar 31, 2025 | SEC |
| Feb 13, 202512:22 PM ET | Cowen Financial Products LLC | 13G/A | 4.90%1.91M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Tarsus Pharmaceuticals, Inc. shares.
No Form 144 notices for Tarsus Pharmaceuticals, Inc. are on file.